z-logo
open-access-imgOpen Access
Melatoninergic antidepressants in the treatment of post-stroke depression
Author(s) -
В. В. Кузнецов
Publication year - 2020
Publication title -
ageing and longevity
Language(s) - English
Resource type - Journals
ISSN - 2709-0205
DOI - 10.47855/jal9020-2020-1-4
Subject(s) - depression (economics) , stroke (engine) , hemodynamics , medicine , cardiology , agomelatine , psychology , cerebral stroke , anesthesia , antidepressant , ischemia , hippocampus , mechanical engineering , engineering , economics , macroeconomics
The article presents data aboutthe impactof the drug Melitor (agomelatine) on the psycho-emotional activity, cerebral hemodynamics, bioelectric activity ofthe brain and their intersystem connectionsinpatients with post-stroke depression. 30 patients with post-stroke depression have been takena dose of Melitor25 mg per day for 2 months. It has been established that Melitor has a positive effect on psycho-emotional activity, improves cerebral hemodynamics, harmonizes the structure of bioelectric activity of the braininpatients with post-stroke depression.Melitor has more strong effect on cerebral hemodynamics and bioelectric activity of the brain inpatients with right-sided stroke than among thepatients with left-sided stroke. Melitor's multimodal influencejustifies the use of the drug during the rehabilitationtreatment of post-stroke patients for the improvementboth functional and psycho-emotional state.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here